Medicare Enrolled

Dr. Samuel Pegram, MD

Rheumatology · Georgetown, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3316 WILLIAMS DR STE 150, Georgetown, TX 78628
5122444272
In practice since 2005 (20 years)
NPI: 1528043130 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pegram from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pegram? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pegram

Dr. Samuel Pegram is a rheumatology in Georgetown, TX, with 20 years in practice. Based on federal Medicare data, Dr. Pegram performed 50,476 Medicare services across 561 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pegram received a total of $18,474 from 52 pharmaceutical and/or device companies across 1021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pegram is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 23% volume in TX$ $18,474 industry payments

Medicare Practice Summary

Medicare Utilization ↗
50,476
Medicare services
Top 23% in TX for rheumatology
561
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,524 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)49,200$4$19
Drug injection, under skin or into muscle280$10$41
Office visit, established patient (30-39 min)255$86$380
Steroid injection (triamcinolone)227$1$10
Injection, zoledronic acid, 1 mg155$6$29
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less62$45$210
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose51$59$258
Office visit, established patient (20-29 min)48$63$267
Office visit, established patient (10-19 min)47$40$164
Aspiration and/or injection of fluid large joint using ultrasound guidance42$92$289
New patient office visit (45-59 min)29$105$490
Drug screening test28$61$600
Joint injection, major joint23$52$187
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms15$226$750
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms14$195$600
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
99.0% medium
0.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$18,474
Total received (2018-2024)
Avg $2,639/year across 7 years
Top 19% in TX for rheumatology
52
Companies
1,021
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,474 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,853
2023
$3,840
2022
$4,027
2021
$2,202
2020
$1,001
2019
$1,775
2018
$1,775

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,825
Aurinia Pharma U.S., Inc.
$1,496
UCB, Inc.
$1,418
Janssen Biotech, Inc.
$1,248
ABBVIE INC.
$1,187
PFIZER INC.
$1,181
Horizon Therapeutics plc
$1,073
AstraZeneca Pharmaceuticals LP
$918
Mallinckrodt Hospital Products Inc.
$856
Boehringer Ingelheim Pharmaceuticals, Inc.
$820
Novartis Pharmaceuticals Corporation
$772
AbbVie, Inc.
$454
Abbott Laboratories
$446
GlaxoSmithKline, LLC.
$403
AbbVie Inc.
$383
Genentech USA, Inc.
$362
Exeltis, USA Inc.
$281
ANI Pharmaceuticals, Inc.
$262
Horizon Pharma plc
$260
Radius Health, Inc.
$259
Lilly USA, LLC
$214
GENZYME CORPORATION
$146
Celgene Corporation
$139
Antares Pharma, Inc.
$125
Mallinckrodt Enterprises LLC
$124
E.R. Squibb & Sons, L.L.C.
$117
Mallinckrodt LLC
$75
Alexion Pharmaceuticals, Inc.
$56
Actelion Pharmaceuticals US, Inc.
$51
Arbor Pharmaceuticals, Inc.
$44
RedHill Biopharma Inc.
$40
MEDEXUS PHARMA, INC.
$39
Astellas Pharma US Inc
$38
Organon Llc
$34
ARBOR PHARMACEUTICALS, INC.
$31
Alnylam Pharmaceuticals Inc.
$30
SI-BONE, Inc.
$24
Biohaven Pharmaceuticals, Inc.
$23
Alkermes, Inc.
$21
West-Ward Pharmaceuticals
$20
United Therapeutics Corporation
$20
SANOFI-AVENTIS U.S. LLC
$19
UPSHER-SMITH LABORATORIES LLC
$19
Organon LLC
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
Assertio Therapeutics, Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Collegium Pharmaceutical, Inc.
$14
Forte Bio-Pharma LLC
$14
Sandoz Inc.
$13
MEDAC PHARMA, INC.
$11
GRT US Holding, Inc.
$11
Top 3 companies account for 31.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ANORO · AVSOLA · Actemra · Aimovig · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · EVENITY · Enbrel · GIVLAARI · HADLIMA · HUMIRA · Horizant · Humira · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · MYRBETRIQ · Mitigare · Movantik · NURTEC ODT · Nucynta · OCTRODE · OFEV · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PROCLAIM · PROLATE · PURIFIED CORTROPHIN GEL · Prolia · Qutenza · RAYOS · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TOSYMRA · TREMFYA · TYVASO · Tymlos · UBRELVY · Uloric · VIMOVO · Vivitrol · XARELTO · XELJANZ · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $37 per 100 Medicare services performed
Looking for a rheumatology in Georgetown?
Compare rheumatologys in the Georgetown area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
14
Per 100K population
2.2
County median income
$108,309
Nearest hospital
ROUND ROCK MEDICAL CENTER
9.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pegram is a mixed practice specialist, with above-average Medicare volume (top 23% in TX), and high industry engagement (low-engagement, top 19%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pegram experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Pegram performed 49,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pegram receive payments from pharmaceutical companies?
Yes. Dr. Pegram received a total of $18,474 from 52 companies across 1,021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pegram's costs compare to other rheumatologys in Georgetown?
Dr. Pegram's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pegram) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →